# Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)

> **NCT05413473** · PHASE1,PHASE2 · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 99 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** MR guided radiotherapy

## Key facts

- **NCT ID:** NCT05413473
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-08
- **Primary completion:** 2029-03-31
- **Final completion:** 2030-01
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05413473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05413473, "Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05413473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*